MICA and non-small cell lung carcinoma: Cisplatin was previously reported to induce the MICA and MICB expression in non-small-cell lung cancer A549 cell line, through DNA stress-induced ATM-ATR signalling, resulting in enhanced sensitivity to NK cell-mediated cytotoxicity [40].